-
1.
公开(公告)号:US4956374A
公开(公告)日:1990-09-11
申请号:US226016
申请日:1988-07-29
申请人: Maki Nishio , Shigeyuki Ando , Takeo Miyaki , Masataka Konishi , Toshikazu Oki
发明人: Maki Nishio , Shigeyuki Ando , Takeo Miyaki , Masataka Konishi , Toshikazu Oki
IPC分类号: C07D417/04 , C12P17/16
CPC分类号: C07D417/04 , C12P17/16 , C12R1/01
摘要: Novel antifungal antibiotic compounds have the structural formula ##STR1## A preferred compound where R is 4-hydroxypentyl is denoted BU-3557B.sub.2. A complex of said compounds is produced by fermenting a culture of Sacchrothrix aerocolonigenes strain N806-4 (ATCC 53712). The complex is recovered by adsorption on nonionic porous polymer resin adsorbent and individual component compounds exhibit in vitro activity against fungi and Gram-positive bacteria and BU-3557B.sub.2 demonstrates in vitro antiprotazoal activity. BU-3557B.sub.2 demonstrates in vivo activity against C. albicans vaginal infection and BU-3557A.sub.3 (where R is 1,5-dihydroxy-5,5-dimethylpentyl) demonstrates in vivo activity against C. albicans systemic infection.
摘要翻译: 新型抗真菌抗生素化合物具有结构式:其中R为4-羟基戊基的优选化合物为BU-3557B2。 通过发酵产气荚膜梭菌菌株N806-4(ATCC 53712)的培养物产生所述化合物的复合物。 通过非离子多孔聚合物树脂吸附剂上的吸附回收复合物,并且各组分化合物表现出对真菌和革兰氏阳性细菌的体外活性,并且BU-3557B2证明体外抗原辅素生物活性。 BU-3557B2证明体内活性针对白色念珠菌阴道感染和BU-3557A3(其中R为1,5-二羟基-5,5-二甲基戊基)表现出对白色念珠菌全身感染的体内活性。